NGALDS
LIVE

Serial Number

79280943

Owner

BioPorto Diagnostics A/S

Attorney

Julie A. Greenberg

Filing Date

Oct 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NGALDS Trademark

Serial Number: 79280943 • Registration: 6358230

NGALDS is a trademark filed by BioPorto Diagnostics A/S on October 28, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BioPorto Diagnostics A/S (2 trademarks)

Tuborg Havnevej 15, st.
2900 Hellerup , DK

Entity Type: 99

Trademark Details

Filing Date

October 28, 2019

Registration Date

May 25, 2021

Published for Opposition

March 9, 2021

Cancellation Date

July 7, 2021

Goods & Services

Pharmaceutical and veterinary preparations for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; biological materials, namely, stem cells for medical and veterinary purposes; biological preparations for medical and veterinary purposes, specifically, for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; diagnostic kits and drug testing kits consisting primarily of stem cells, antibodies and proteins for medical and veterinary purposes for the prevention, alleviation and treatment of acute kidney injury (AKI), diabetes, inflammatory diseases; reagents for medical diagnosis and/or analysis; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test materials, namely, comprising diagnostic agents, preparations and substances for medical use; diagnostic kits comprising primarily diagnostic agents, preparations and substances for medical use; biological materials, namely, monoclonal antibodies for use in medical research, namely, in vitro diagnostic tests and disease testing

Chemicals used in industry and science; stem cells for research and scientific purposes; biochemical, namely, monoclonal antibodies for in vitro diagnostic scientific or industrial research; cells for scientific and research use, namely, DNA and RNA preparations for scientific and industrial purposes; proteins for use within science, namely, protein in raw material form for scientific research, protein assays for scientific research; diagnostic kits consisting primarily of monoclonal stem cells, antibodies and proteins for scientific research, in vitro diagnostic tests and disease testing; chemical reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; diagnostic test materials, namely, comprising diagnostic reagents, for scientific purposes, not for medical or veterinary purposes; assays for research purposes

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 23, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 23, 2021 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 17, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 17, 2021 DETH
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 12, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 12, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 7, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2021 CRFA
ASSIGNED TO LIE
Jan 7, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 1, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 21, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2020 REPR